Abdominal Imaging

, Volume 31, Issue 6, pp 632–643

Cross-sectional imaging of nodal metastases in the abdomen and pelvis



Accurate nodal staging is important for the management of patients with abdominal and pelvic malignancies. Local and nodal staging using cross-sectional imaging can influence treatment planning. The measurement of nodal size is still the most widely used criteria for discriminating between benign and malignant nodes. However, knowledge of the pathways of nodal spread, the treatment history, and careful analysis of nodal characteristics can improve nodal assessment. An appreciation of normal structures that may simulate nodal disease is also important. The potential for further improving nodal staging accuracy by positron emission tomography and magnetic resonance lymphography is discussed.


Abdomen Nodes Pelvis Staging 


  1. 1.
    Tiguert R, Gheiler EL, Tefilli MV, et al. (1999) Lymph node size does not correlate with the presence of prostate cancer metastasis. Urology 53:367–371PubMedCrossRefGoogle Scholar
  2. 2.
    Lucey BC, Stuhlfaut JW, Soto JA (2005) Mesenteric lymph nodes: detection and significance on MDCT. AJR 184:41–44PubMedGoogle Scholar
  3. 3.
    Brown G, Richards CJ, Bourne MW, et al. (2003) Morphologic predictors of lymph node status in rectal cancer with use of high-spatial-resolution MR imaging with histopathologic comparison. Radiology 227:371–377PubMedGoogle Scholar
  4. 4.
    Jager GJ, Barentsz JO, Oosterhof GO, Witjes JA, Ruijs SJ (1996) Pelvic adenopathy in prostatic and urinary bladder carcinoma: MR imaging with a three-dimensional TI-weighted magnetization-prepared-rapid gradient-echo sequence. AJR 167:1503–1507PubMedGoogle Scholar
  5. 5.
    Dorfman RE, Alpern MB, Gross BH, Sandler MA (1991) Upper abdominal lymph nodes: criteria for normal size determined with CT. Radiology 180:319–322PubMedGoogle Scholar
  6. 6.
    Magnusson A (1983) Size of normal retroperitoneal lymph nodes. Acta Radiol Diagn (Stockh) 24:315–318Google Scholar
  7. 7.
    Einstein DM, Singer AA, Chilcote WA, Desai RK (1991) Abdominal lymphadenopathy: spectrum of CT findings. Radiographics 11:457–472PubMedGoogle Scholar
  8. 8.
    Vinnicombe SJ, Norman AR, Nicolson V, Husband JE (1995) Normal pelvic lymph nodes: evaluation with CT after bipedal lymphangiography. Radiology 194:349–355PubMedGoogle Scholar
  9. 9.
    Peters PE, Beyer K (1985) [Normal lymph node cross sections in different anatomic regions and their significance for computed tomographic diagnosis]. Radiologe 25:193–198PubMedGoogle Scholar
  10. 10.
    Balfe DM, Mauro MA, Koehler RE, et al. (1984) Gastrohepatic ligament: normal and pathologic CT anatomy. Radiology 150:485–490PubMedGoogle Scholar
  11. 11.
    Grey AC, Carrington BM, Hulse PA, Swindell R, Yates W (2000) Magnetic resonance appearance of normal inguinal nodes. Clin Radiol 55:124–130PubMedCrossRefGoogle Scholar
  12. 12.
    Zirinsky K, Auh YH, Rubenstein WA, Kneeland JB, Whalen JP, Kazam E (1985) The portacaval space: CT with MR correlation. Radiology 156:453–460PubMedGoogle Scholar
  13. 13.
    Bundrick WS, Culkin DJ, Mata JA, Zitman RI, Venable DD (1993) Evaluation of the current incidence of nodal metastasis from prostate cancer. J Surg Oncol 52:269–271PubMedCrossRefGoogle Scholar
  14. 14.
    Neal AJ, Dearnaley DP (1993) Prostate cancer: pelvic nodes revisited–sites, incidence and prospects for treatment with radiotherapy. Clin Oncol (R Coll Radiol) 5:309–312Google Scholar
  15. 15.
    Spencer J, Golding S (1992) CT evaluation of lymph node status at presentation of prostatic carcinoma. Br J Radiol 65:199–201PubMedGoogle Scholar
  16. 16.
    Sakuragi N, Satoh C, Takeda N, et al. (1999) Incidence and distribution pattern of pelvic and paraaortic lymph node metastasis in patients with Stages IB, IIA, and IIB cervical carcinoma treated with radical hysterectomy. Cancer 85:1547–1554PubMedCrossRefGoogle Scholar
  17. 17.
    Sohn KM, Lee JM, Lee SY, Ahn BY, Park SM, Kim KM (2000) Comparing MR imaging and CT in the staging of gastric carcinoma. AJR 174:1551–1557PubMedGoogle Scholar
  18. 18.
    Brown G, Radcliffe AG, Newcombe RG, Dallimore NS, Bourne MW, Williams GT (2003) Preoperative assessment of prognostic factors in rectal cancer using high-resolution magnetic resonance imaging. Br J Surg 90:355–364PubMedCrossRefGoogle Scholar
  19. 19.
    Nicolai N, Miceli R, Artusi R, Piva L, Pizzocaro G, Salvioni R (2004) A simple model for predicting nodal metastasis in patients with clinical stage I nonseminomatous germ cell testicular tumors undergoing retroperitoneal lymph node dissection only. J Urol 171:172–176PubMedCrossRefGoogle Scholar
  20. 20.
    Marks LB, Rutgers JL, Shipley WU, et al. (1990) Testicular seminoma: clinical and pathological features that may predict para-aortic lymph node metastases. J Urol 143:524–527PubMedGoogle Scholar
  21. 21.
    Partin AW, Mangold LA, Lamm DM, Walsh PC, Epstein JI, Pearson JD (2001) Contemporary update of prostate cancer staging nomograms (Partin tables) for the new millennium. Urology 58:843–848PubMedCrossRefGoogle Scholar
  22. 22.
    Golimbu M, Morales P, Al-Askari S, Brown J (1979) Extended pelvic lymphadenectomy for prostatic cancer. J Urol 121:617–620PubMedGoogle Scholar
  23. 23.
    Park JM, Charnsangavej C, Yoshimitsu K, Herron DH, Robinson TJ, Wallace S (1994) Pathways of nodal metastasis from pelvic tumors: CT demonstration. Radiographics 14:1309–1321PubMedGoogle Scholar
  24. 24.
    Chintapalli KN, Esola CC, Chopra S, Ghiatas AA, Dodd GD 3rd (1997) Pericolic mesenteric lymph nodes: an aid in distinguishing diverticulitis from cancer of the colon. AJR 169:1253–1255PubMedGoogle Scholar
  25. 25.
    Efremidis SC, Vougiouklis N, Zafiriadou E, et al. (1999) Pathways of lymph node involvement in upper abdominal malignancies: evaluation with high-resolution CT. Eur Radiol 9:868–874PubMedCrossRefGoogle Scholar
  26. 26.
    Koh DM, Husband JE (2003) Pattern of disease recurrence of bladder carcinoma following radical cystectomy. Cancer Imaging 3:96–100Google Scholar
  27. 27.
    Husband JE, MacVicar D (1998) Testicular germ cell tumour. In: Husband JE, Reznek RH (eds). Imaging in oncology. Oxford: ISIS Medical Media, 259–276Google Scholar
  28. 28.
    Hilton S, Herr HW, Teitcher JB, Begg CB, Castellino RA (1997) CT detection of retroperitoneal lymph node metastases in patients with clinical stage I testicular nonseminomatous germ cell cancer: assessment of size and distribution criteria. AJR 169:521–525PubMedGoogle Scholar
  29. 29.
    Oyen RH, Van Poppel HP, Ameye FE, Van de Voorde WA, Baert AL, Baert LV (1994) Lymph node staging of localized prostatic carcinoma with CT and CT-guided fine-needle aspiration biopsy: prospective study of 285 patients. Radiology 190:315–322PubMedGoogle Scholar
  30. 30.
    Steinkamp HJ, Cornehl M, Hosten N, Pegios W, Vogl T, Felix R (1995) Cervical lymphadenopathy: ratio of long- to short-axis diameter as a predictor of malignancy. Br J Radiol 68:266–270PubMedCrossRefGoogle Scholar
  31. 31.
    Fukuya T, Honda H, Hayashi T, et al. (1995) Lymph-node metastases: efficacy for detection with helical CT in patients with gastric cancer. Radiology 197:705–711PubMedGoogle Scholar
  32. 32.
    Lien HH, Lindskold L, Stenwig AE, Ous S, Fossa SD (1987) Shape of retroperitoneal lymph nodes at computed tomography does not correlate to metastatic disease in early stage non-seminomatous testicular tumors. Acta Radiol 28:271–273PubMedCrossRefGoogle Scholar
  33. 33.
    Roche CJ, Hughes ML, Garvey CJ, et al. (2003) CT and pathologic assessment of prospective nodal staging in patients with ductal adenocarcinoma of the head of the pancreas. AJR 180:475–480PubMedGoogle Scholar
  34. 34.
    Matsukuma K, Tsukamoto N, Matsuyama T, Ono M, Nakano H (1989) Preoperative CT study of lymph nodes in cervical cancer—its correlation with histological findings. Gynecol Oncol 33:168–171PubMedCrossRefGoogle Scholar
  35. 35.
    Yang WT, Lam WW, Yu MY, Cheung TH, Metreweli C (2000) Comparison of dynamic helical CT and dynamic MR imaging in the evaluation of pelvic lymph nodes in cervical carcinoma. AJR 175:759–766PubMedGoogle Scholar
  36. 36.
    Scatarige JC, Fishman EK, Kuhajda FP, Taylor GA, Siegelman SS (1983) Low attenuation nodal metastases in testicular carcinoma. J Comput Assist Tomogr 7:682–687PubMedCrossRefGoogle Scholar
  37. 37.
    Husband JE, Hawkes DJ, Peckham MJ (1982) CT estimations of mean attenuation values and volume in testicular tumors: a comparison with surgical and histologic findings. Radiology 144:553–558PubMedGoogle Scholar
  38. 38.
    Barentsz JO, Jager GJ, van Vierzen PB, et al. (1996) Staging urinary bladder cancer after transurethral biopsy: value of fast dynamic contrast-enhanced MR imaging. Radiology 201:185–193PubMedGoogle Scholar
  39. 39.
    Noworolski SM, Fischbein NJ, Kaplan MJ, et al. (2003) Challenges in dynamic contrast-enhanced MRI imaging of cervical lymph nodes to detect metastatic disease. J Magn Reson Imaging 17:455–462PubMedCrossRefGoogle Scholar
  40. 40.
    Husband JE, Koh DM (2004) Bladder cancer. In: Husband JE, Reznek RH (eds). Imaging in oncology. 2nd ed. London: Taylor and Francis, 343–374Google Scholar
  41. 41.
    Dooms GC, Hricak H, Moseley ME, Bottles K, Fisher M, Higgins CB (1985) Characterization of lymphadenopathy by magnetic resonance relaxation times: preliminary results. Radiology 155:691–697PubMedGoogle Scholar
  42. 42.
    Kim SH, Choi BI, Lee HP, et al. (1990) Uterine cervical carcinoma: comparison of CT and MR findings. Radiology 175:45–51PubMedGoogle Scholar
  43. 43.
    Kim SH, Kim SC, Choi BI, Han MC (1994) Uterine cervical carcinoma: evaluation of pelvic lymph node metastasis with MR imaging. Radiology 190:807–811PubMedGoogle Scholar
  44. 44.
    Williams AD, Cousins C, Soutter WP, et al. (2001) Detection of pelvic lymph node metastases in gynecologic malignancy: a comparison of CT, MR imaging, and positron emission tomography. AJR 177:343–348PubMedGoogle Scholar
  45. 45.
    Fukuda H, Nakagawa T, Shibuya H (1999) Metastases to pelvic lymph nodes from carcinoma in the pelvic cavity: diagnosis using thin-section CT. Clin Radiol 54:237–242PubMedCrossRefGoogle Scholar
  46. 46.
    Salo JO, Kivisaari L, Rannikko S, Lehtonen T (1986) The value of CT in detecting pelvic lymph node metastases in cases of bladder and prostate carcinoma. Scand J Urol Nephrol 20:261–265PubMedGoogle Scholar
  47. 47.
    Subak LL, Hricak H, Powell CB, Azizi L, Stern JL (1995) Cervical carcinoma: computed tomography and magnetic resonance imaging for preoperative staging. Obstet Gynecol 86:43–50PubMedCrossRefGoogle Scholar
  48. 48.
    Sugiyama T, Nishida T, Ushijima K, et al. (1995) Detection of lymph node metastasis in ovarian carcinoma and uterine corpus carcinoma by preoperative computerized tomography or magnetic resonance imaging. J Obstet Gynaecol 21:551–556PubMedGoogle Scholar
  49. 49.
    Teefey SA, Baron RL, Schulte SJ, Shuman WP (1990) Differentiating pelvic veins and enlarged lymph nodes: optimal CT techniques. Radiology 175:683–685PubMedGoogle Scholar
  50. 50.
    Gollub MJ, Castellino RA (1996) The cisterna chyli: a potential mimic of retrocrural lymphadenopathy on CT scans. Radiology 199:477–480PubMedGoogle Scholar
  51. 51.
    Koh DM, Brown G, Temple L, et al. (2004) Rectal cancer: mesorectal lymph nodes at MR imaging with USPIO versus histopathologic findings—initial observations. Radiology 231:91–99PubMedGoogle Scholar
  52. 52.
    Bellin MF, Lebleu L, Meric JB (2003) Evaluation of retroperitoneal and pelvic lymph node metastases with MRI and MR lymphangiography. Abdom Imaging 28:155–163PubMedCrossRefGoogle Scholar
  53. 53.
    Harisinghani MG, Barentsz J, Hahn PF, et al. (2003) Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med 348:2491–2499PubMedCrossRefGoogle Scholar
  54. 54.
    Deserno WM, Harisinghani MG, Taupitz M, et al. (2004) Urinary bladder cancer: preoperative nodal staging with ferumoxtran-10-enhanced MR imaging. Radiology 233:449–456PubMedGoogle Scholar
  55. 55.
    Harisinghani MG, Saini S, Slater GJ, Schnall MD, Rifkin MD (1997) MR imaging of pelvic lymph nodes in primary pelvic carcinoma with ultrasmall superparamagnetic iron oxide (Combidex): preliminary observations. J Magn Reson Imaging 7:161–163PubMedCrossRefGoogle Scholar
  56. 56.
    Reinhardt MJ, Ehritt-Braun C, Vogelgesang D, et al. (2001) Metastatic lymph nodes in patients with cervical cancer: detection with MR imaging and FDG PET. Radiology 218:776–782PubMedGoogle Scholar
  57. 57.
    Horowitz NS, Dehdashti F, Herzog TJ, et al. (2004) Prospective evaluation of FDG-PET for detecting pelvic and para-aortic lymph node metastasis in uterine corpus cancer. Gynecol Oncol 95:546–551PubMedCrossRefGoogle Scholar
  58. 58.
    Hutchings M, Eigtved AI, Specht L (2004) FDG-PET in the clinical management of Hodgkin lymphoma. Crit Rev Oncol Hematol 52:19–32PubMedGoogle Scholar
  59. 59.
    Burton C, Ell P, Linch D (2004) The role of PET imaging in lymphoma. Br J Haematol 126:772–784PubMedCrossRefGoogle Scholar
  60. 60.
    Huddart RA (2003) Use of FDG-PET in testicular tumours. Clin Oncol (R Coll Radiol) 15:123–127Google Scholar
  61. 61.
    Graham RA, Garnsey L, Jessup JM (1990) Local excision of rectal carcinoma. Am J Surg 160:306–312PubMedCrossRefGoogle Scholar
  62. 62.
    Herr HW (1988) Bladder cancer: pelvic lymphadenectomy revisited. J Surg Oncol 37:242–245PubMedCrossRefGoogle Scholar
  63. 63.
    Lerner SP, Skinner DG, Lieskovsky G, et al. (1993) The rationale for en bloc pelvic lymph node dissection for bladder cancer patients with nodal metastases: long-term results. J Urol 149:758–764, discussion 764–755PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, Inc. 2006

Authors and Affiliations

  1. 1.Academic Department of RadiologyRoyal Marsden HospitalSuttonUK

Personalised recommendations